Position in IBRX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$3,835
New position
Shares Held
500
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026TSFG, LLC holds $256,557 across 17 Biotechnology names. IBRX ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DAWN |
Day One Biopharmaceuticals, Inc.
|
3,400 | $72,896 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
75 | $57,948 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
107 | $47,779 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
380 | $23,826 | |
| 5 | ADMA |
Adma Biologics, Inc.
|
2,569 | $23,146 | |
| 6 | BNTX |
BioNTech SE
|
178 | $15,820 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
40 | $7,562 | |
| 8 | IBRX |
ImmunityBio, Inc.
This page
|
500 | $3,835 |
All Filings in IBRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,835 | 500 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||